| RESULTS
During the study period, 287 salivary gland FNA samples were received from 134 male (49.3%) and 138 female (50.7%) patients, mean age 57 years (range 14-96 years). The sites sampled were: parotid gland (n = 209, 72.8%), submandibular gland (n = 69, 24%), pre-auricular (n = 1, 0.3%), neck not otherwise specified (n = 4, 1.4%) and neck levels 1b and 2 (n = 2, 0.7% each). Just over half of the specimens were obtained under radiological guidance (ultrasound n = 145, 50.5%; computed tomography n = 1, 0.3%) with slightly more from the left side (n = 147, 51.2%) as opposed to the right (n = 140, 48.8%).
The number of cases assigned to each diagnostic category with the cytological diagnoses are outlined in Table 2 . 27 (18.6%) FNAs performed under ultrasound guidance were found to be non-diagnostic as opposed to 34 (24.1%) of those performed without imaging guidance. The use of ultrasound therefore reduced the number of nondiagnostic samples and the need for a repeat procedure by 5.5%.
Histological and clinical/radiological follow up was available for 138 (48.1%) specimens, clinical/radiological follow up only for 145 (50.5%) and no follow up for the remaining four (1.4%) samples. The cytological correlation with histology/radiology and clinical follow up is demonstrated in Table 3 with discrepant cases in Table 4 . Four cases were diagnosed as possible Warthin tumour on FNAC, three of which showed non-neoplastic entities on follow up histology. This is probably due to the overlapping cytological features, which may be seen in these entities.
The other case showed extranodal marginal zone lymphoma on histology which probably represents a sampling error. There were an additional two discrepant cases in which histology was not available. One case was a neck FNA reported on cytology as chronic sialadenitis (non-neoplastic) in a patient with previous squamous cell carcinoma of the tongue and nodal recurrence on imaging. The other was reported as a basaloid neoplasm which was thought to represent duct obstruction on magnetic resonance imaging scan and clinical follow up with no change on follow up imaging (non-neoplastic).
There were seven cases in the atypia of undetermined significance category, which were all benign on follow up (two with histology, two with cytology and three with clinical follow up) with five cases reported as suspicious for malignancy that all had histological follow up ( Table 5 ).
All of the calculated parameters for cases with corresponding histology were within the published ranges used as standards in this study ( Table 6 ). The calculated risk of malignancy (ROM) for each category is outlined in Table 7 and is comparable to those proposed in the MSRSGC in all categories, apart from the suspicious category, which is higher. Pleomorphic adenoma may also be included in the differential diagnosis of a basaloid neoplasm; however, identification of matrix material is the key feature.
| DISCUSSION
There was an interesting case in our study where the cytological diagnosis was given as a possible skin adnexal tumour, such as pilomatrixoma; however, the histology showed NUT carcinoma. This could be due to the presence of abundant keratinisation and squamous differentiation in the poorly differentiated tumour, which was misinterpreted as a pilomatrixoma. Encountering rare entities in FNAC specimens is a diagnostic challenge.
Reviewing the cytological findings in light of the histological features in discrepant cases is a useful learning exercise for ongoing professional development.
Careful and proper utilisation of the neoplasm SUMP category will help to reduce the number of false positive and false negative cases where the differential diagnosis includes both benign and malignant entities.
In addition to the neoplasm SUMP category, the other two inde- 
| CONCLUSIONS
The cytological diagnosis of salivary gland lesions may be challenging due to a diverse number of salivary gland tumours, tumour heterogeneity and overlapping features between tumours. The diagnostic service provided by our cytopathology department is of high quality and comparable to published practice. The MSRSGC appears to be a useful tool to guide clinical management and provide an indication of possible risk of malignancy. We would favour implementing use of these categories in our reporting practice with a future re-evaluation to assess maintenance of service quality as well as the clinical utility of this reporting system.
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